Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Drugs Controller General of India DCGI

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Read More

Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India

Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India

Read More

Biocon's Drug Itolizumab Gets DCGI Nod For Use In Moderate To Severe Covid-19 Patients

Itolizumab will be manufactured and formulated as an intravenous injection at Biocon's bio-manufacturing facility at Biocon Park in Bengaluru.

Read More